How and why pharmaceutical reforms contribute to universal health coverage through improving equitable access to medicines

A case of Ghana

Datos Bibliográficos

ID22081007
AutoresAugustina Koduah (0000-0001-9915-5333, University of Ghana, autor de correspondencia)
Año2023
Volumen11
Páginas1163342-1163342
Fecha de publicación2023-07-07
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaFrontiers in Public Health (JOURNAL)
Identificadores de la revistaISSN: 2296-2565 • E-ISSN: 2296-2565
EditorialFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2023.1163342
PMID37483923
OpenAlexW4383553894
IdiomaEN
Citas recibidas1
Referencias citadas25

Background: Examining how and why a country prioritizes and implements pharmaceutical reforms tends to show complex processes and myriad efforts made toward improving access to medicines. This study examines factors that enabled the prioritization and implementation of selected pharmaceutical reform items and how these factors contributed to improving equitable access to medicines and universal health coverage in Ghana. Methods: An analytical framework was developed to identify variables to explore in answering the study questions and frame the analysis and presentation of findings. Documents analyzed included the National Medicines Policies, Health Sector Program of Work, and other health policies. Quantitative data were sourced from databases maintained by World Health Organization and the Institute for Health Metrics and Evaluation. Results: The three main factors, evidence, financial and technical support, and alignment to national and global policies, influenced the prioritization and implementation of access to medicines reforms. The reforms targeted rational selection and use of medicines, medicine pricing, sustainable medicine financing, and regulatory and supply chain systems. Although there were limited quantitative data to quantify access to medicine policies" impact on universal health coverage, it can be reasonably assumed that, in Ghana, access to medicine policies has contributed to financial protection and improved access to quality health services. Conclusion: Access to medicine policies targeted at promoting rational medicine selection and use, regulating medicine pricing and improving sustainable financing for medicines as well as the regulatory and supply chain systems arguably contributed to the attainment of UHC and must be sustained. Therefore, data collection and reporting indicators for access to medicines must be prioritized

Access to medicines · Business · Developing country · Economic growth · Economics · Essential medicines · Health care · Pharmaceutical policy · Public economics · Supply chain · Universal design · Computer Science · Healthcare Systems and Reforms · Pharmaceutical Economics and Policy · Pharmaceutical Quality and Counterfeiting · Health Policy · Marketing